ANG Lifesciences India (ANG) Rating, Buy/Sell, Forecast, Analysis

Details

Name	Symbol	Sector
ANG LIFESCIENCES INDIA LIMITED	ANG	Pharmaceuticals

Open

31.42

High

31.55

Low

31.42

Close

31.42

Volume

713

Exchange

bse

Time

14-Aug-2026

Outlook

Score: 1.75
Rating: RISKY

Candlestick Pattern

Candle pattern of Ang Lifesciences India is Doji
Estimated Stoploss of Ang Lifesciences India is ₹ 31.55
Ang Lifesciences India has a Bearish pattern.
Formation of Doji candle pattern indicates the trend direction of Ang Lifesciences India is Unpredictable .

Trend

Ang Lifesciences India is in Sideways trend .
Price of Ang Lifesciences India is Down by 6.04 %.

Target

Buy @ 24.34
Sell @ 39.66
Current @ 31.42

Volume

The trade volumes of Ang Lifesciences India have become Deficient
The volume trend for Ang Lifesciences India is Bearish , but the participants are Weak Sellers
The trade volume of Ang Lifesciences India is Down by 92.62 %

Valuation

The current market price of Ang Lifesciences India is Undervalued

Financials

Balance
With total liablities and shareholder equity worth ₹ 229cr and total assets worth ₹ 229cr, the balance sheet of Ang Lifesciences India is: Balanced .

Cashflow
Ang Lifesciences India has Insufficient cash flow because it is ₹ 0cr . It is Down by 0 %. (*Mar 2025) 0% in operating 50% i.e. ₹ 1cr spent in investing 50% i.e. ₹ 1cr earned in financing 0% in other
Ang Lifesciences India has Insufficient cash flow because it is ₹ 0cr . It is Down by 0 %. (*Mar 2024) 23.68% i.e. ₹ 9cr spent in operating 50% i.e. ₹ 19cr earned in investing 26.32% i.e. ₹ 10cr spent in financing 0% in other

Income
The income of Ang Lifesciences India is ₹ 26cr and Loss is : ₹ 2cr (Sep 2025) Ang Lifesciences India Losses increased by: 0 % and Income is Up by: 8.33 % (Sep 2025)
The income of Ang Lifesciences India is ₹ 24cr and Loss is : ₹ 2cr (Jun 2025) Ang Lifesciences India Losses increased by: 0 % and Income is Up by: 41.18 % (Jun 2025)
The income of Ang Lifesciences India is ₹ 17cr and Loss is : ₹ 2cr (Mar 2025) Ang Lifesciences India Losses decreased by: 60 % and Income is Down by: 29.17 % (Mar 2025)

Market Cap

Market capital of ANG Lifesciences India Limited is 38cr

Top Rated Competitors

Name	Score
Jenburkt Pharmaceuticals Ltd.	6.25
KIMIA BIOSCIENCES LIMITED	5.75
Neuland Laboratories Limited.	5.75
Sanjivani Paranteral Ltd.	5.75
Lactose (India) Ltd.	5.5
Shukra Pharmaceuticals Limited	5.5
Marksans Pharma Ltd.	5.5
Venus Remedies Ltd.	5.25
Coral Laboratories Ltd.	5.25
Morepen Laboratories Ltd.	5

By using this site you agree to the use of cookies to deliver a better site experience.